212. Tricuspid atresia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 5 / Drugs : 6 - (DrugBank : 6) / Drug target genes : 8 - Drug target pathways : 12
Drugs and their primary sponsors and trial info
Bosentan
Rigshospitalet, Denmark
2011 Phase 2 NCT01292551 Denmark;Sweden;
Dexmedetomidine
Athena Zuppa
2004 Phase 1 NCT00573066 -
Liothyronine I 131
FDA Office of Orphan Products Development
1994 Phase 1 NCT00004828 -
Methacetin Breath Test (MBT)
Northwestern University
2019 - NCT04176458 United States;
Sildenafil
Children's Hospital of Philadelphia
2007 Phase 2 NCT00507819 United States;
Vitamin C
University of Michigan
2009 - NCT00974025 United States;
Rigshospitalet, Denmark
2011 Phase 2 NCT01292551 Denmark;Sweden;
Dexmedetomidine
Athena Zuppa
2004 Phase 1 NCT00573066 -
Liothyronine I 131
FDA Office of Orphan Products Development
1994 Phase 1 NCT00004828 -
Methacetin Breath Test (MBT)
Northwestern University
2019 - NCT04176458 United States;
Sildenafil
Children's Hospital of Philadelphia
2007 Phase 2 NCT00507819 United States;
Vitamin C
University of Michigan
2009 - NCT00974025 United States;